ReviewFrontiers in microbiology2026
Genes and physiological strategies in bacterial antibiotic resistance.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacteria display an incredible genetic plasticity, which enables them to adapt to various environmental stressors, such as antibiotic compounds that may imperil their existence. Bacterial resistance mechanisms include degradative enzymes, inactivation of antibiotics, antibacterial target site mutation, change in target, altered cell wall permeability to antibiotics, bypass of metabolic pathways, and efflux pumping of antibiotics across the cell membrane. These mechanisms are encoded by genomic changes ranging from point mutation via genetic elements assembly to horizontal transfer of genes from the environment. Antibiotic resistance in bacteria can be inherited or acquired. Antibacterial resistance genes may accumulate mobile elements, leading to multi-drug-resistant phenotypic transfer via a single genetic event. The resistance to antibiotics has been frequently increasing in clinical settings, which drives scientists to research alternative antibacterial medicines to prevent the growth and spread of drug-resistant bacteria. Technological advancements and the discovery of innovative drug moieties with targeting potential have led to the development of novel drug compounds with diverse therapeutic properties. This includes alternative cellular, physiological, and metabolic patterns of bacteria that may be potential pharmacological targets for the next generation of antibiotics. It is beneficial to characterize antibiotic resistance genotypes and phenotypes causing antibiotic bacterial resistance. An understanding of mechanisms that lead to the development and spread of antibiotic resistance will help clinicians in making appropriate decisions regarding antibiotic usage in a wide range of circumstances. The current review has highlighted the mechanism of drug resistance in bacteria, and has enlisted the antibiotic resistance genes (ARGs) and their importance in aggravating the resistance phenomenon.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.